Primary Effusion Lymphoma in an Hiv-Negative Patient with No Serologic Evidence of Kaposi's Sarcoma Virus

2001 ◽  
Vol 41 (1-2) ◽  
pp. 185-189 ◽  
Author(s):  
Jose Rodriguez ◽  
Jorge E. Romaguera ◽  
Ruth L. Katz ◽  
Jonathan Said ◽  
Fernando Cabanillas
Keyword(s):  
Kaposi's Sarcoma ◽  
Primary Effusion Lymphoma ◽  
Kaposi’S Sarcoma ◽  
Negative Patient ◽  
Serologic Evidence ◽  
Sarcoma Virus ◽  
Hiv Negative

scholarly journals Kaposi’s sarcoma in an HIV-negative patient

2016 ◽  
Vol 22 (12) ◽  
Author(s):  
Shields Callahan ◽  
Randie H Kim ◽  
Nooshin Brinster ◽  
Jo-Ann Latkowski
Keyword(s):  
Kaposi's Sarcoma ◽  
Kaposi’S Sarcoma ◽  
Negative Patient ◽  
Hiv Negative

scholarly journals Simultaneous Association of Pulmonary Tuberculosis and Kaposi’s Sarcoma in an Immunocompetent Subject: A Case Report and Literature Review

2019 ◽  
Vol 2019 ◽  
pp. 1-3
Author(s):  
Sofia Baina ◽  
Jihane Achrane ◽  
Jouda Benamor ◽  
Jamal Eddine Bourkadi
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Pulmonary Tuberculosis ◽  
Kaposi's Sarcoma ◽  
Kaposi’S Sarcoma ◽  
Hiv Positive ◽  
Negative Patient ◽  
Different Types ◽  
Hiv Negative

Kaposi’s Sarcoma (KS) occurs as a pathological entity that may be classified into four different types: classic, endemic, epidemic, and iatrogenic. It can arise among HIV-positive subjects or within immunosuppression, yet exceptionally of tuberculous origin. We describe a new case report of an HIV-negative patient, manifesting Kaposi’s disease in the course of tuberculosis, with the aim to assess this uncommon disorder and to outline this rare atypical association.

Anaplastic Kaposi’s Sarcoma of the Adrenal in an HIV-negative Patient With Literature Review

2019 ◽  
Vol 26 (2) ◽  
pp. 133-149
Author(s):  
Michele Bisceglia ◽  
Elena Minenna ◽  
Andrea Altobella ◽  
Francesca Sanguedolce ◽  
Gaetano Panniello ◽  
...  
Keyword(s):  
Literature Review ◽  
Kaposi's Sarcoma ◽  
Kaposi’S Sarcoma ◽  
Negative Patient ◽  
Hiv Negative

A Case of Kaposi’s Sarcoma in a HIV Negative Patient with CLL Treated with Rituximab

Blood ◽  
2014 ◽  
Vol 124 (21) ◽  
pp. 4970-4970
Author(s):  
Anuradha Avinash Belur ◽  
Arun Kumar Arumugam Raajasekar ◽  
Srikant Nannapaneni ◽  
Thandavababu Chelliah
Keyword(s):  
Kaposi's Sarcoma ◽  
Conflicts Of Interest ◽  
Kaposi Sarcoma ◽  
Kaposi’S Sarcoma ◽  
Skin Lesions ◽  
Elisa Test ◽  
Lymphocytic Leukemia ◽  
Cell Mediated Immunity ◽  
Negative Patient ◽  
Hiv Negative

Abstract Case Description: - A 76 year old lady was diagnosed with Chronic Lymphocytic Leukemia (CLL) with 11 q deletion after she presented with generalized lymphadenopathy and anemia. She was treated with rituximab 375mg/m2 day1 and bendamustine 60mg/m2 on day 1 and day 2 and completed six cycles of treatment. After the sixth cycle she developed multiple itchy, papular lesions with bleeding on both lower extremities. She was evaluated multiple times by vascular surgery and dermatology without a definitive diagnosis. She underwent a biopsy with staining for HHV-8, CD31 and CD34 which was positive confirming the diagnosis of Kaposi sarcoma. ELISA test for HIV was negative. She was started on treatment with Doxorubicin 20 mg/m2every 3 weeks and with 3 cycles there was significant regression of the lesions. Discussion-: We describe a case of CLL which was initially started on treatment with rituximab and bendamustine. She tolerated the treatment well, but a few months later presented with skin lesions which on biopsy was diagnosed as Kaposi sarcoma. It is very uncommon for Kaposi sarcoma to develop in a HIV negative patient. This patient was immunocompromised with recent chemotherapy. Rituximab specifically depletes B cells and leads to impaired T cell mediated immunity. This case illustrates the importance of a high index of suspicion in patients treated with rituximab as it is used for a number of hematologic malignancies like leukemia, lymphoma as well as non-malignant conditions like autoimmune disorders. While infusion reactions and reactivation of hepatitis B are side effects physicians are aware of and cautious of while using rituximab, Kaposi’s Sarcoma remains a less known side effect. Awareness of this possibility is important in physicians prescribing rituximab. Footnotes * Asterisk with author names denotes non-ASH members. Disclosures No relevant conflicts of interest to declare.

Sign in / Sign up

Export Citation Format

Share Document